Skip to main content
Year archive

DR REDDYS LABORATORIES LTD — 2021 filings

All 208 regulatory filings released by DR REDDYS LABORATORIES LTD (RDY) in 2021, sourced directly from the official regulator.

208 Filings
2021 Period
2021 filings (208)
Filing Released Lang
FORM 6-K
Regulatory Filings
2021-12-28 English
Intimation regarding closure of trading window
Board/Management Information
2021-12-28 English
DR.REDDY''s LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/01/2022 ,inter alia, to consider and approve Unaudited Financial ....
Board/Management Information
2021-12-28 English
Press Release
Regulatory Filings
2021-12-28 English
6-K Filing
Regulatory Filings
2021-12-20 English
ESOP intimation
Share Issue/Capital Change
2021-12-18 English
FORM 6-K
Regulatory Filings
2021-12-10 English
Intimation
Regulatory Filings
2021-12-10 English
Intimation
Regulatory Filings
2021-12-10 English
FORM 6-K
Regulatory Filings
2021-12-10 English
Dr. Reddy''s Laboratories announces the launch of Venlafaxine ER Tablets in the U.S. Market
Capital/Financing Update
2021-12-09 English
FORM 6-K
Regulatory Filings
2021-12-09 English
Dr. Reddy''s Laboratories announces the launch of Valsartan Tablets, USP in the U.S. Market
Regulatory Filings
2021-12-09 English
Press Release
Capital/Financing Update
2021-12-09 English
Intimation regarding issue of duplicate share certificates
Regulatory Filings
2021-11-12 English
FORM 6-K
Regulatory Filings
2021-11-08 English
6-K Filing
Call Transcript
2021-11-08 English
Intimation regarding filing of Form 6k For Q2-FY22
Interim / Quarterly Report Q2 2022
2021-11-06 English
FORM 6-K
Interim / Quarterly Report
2021-11-05 English
Earnings call transcript Q2 FY22
Call Transcript
2021-11-05 English
FORM 6-K
Regulatory Filings
2021-11-01 English
FORM 6-K
Regulatory Filings
2021-11-01 English
Newspaper Ad Q2 and H1 FY22 financial results
Interim / Quarterly Report H1 2022
2021-10-30 English
FORM 6-K
Regulatory Filings
2021-10-29 English
Intimation regarding earnings call recording link - Q2FY22 financials
Regulatory Filings
2021-10-29 English
Press Release
Capital/Financing Update
2021-10-29 English
GRant of stock options
Share Issue/Capital Change
2021-10-29 English
Allotment of ESOP
Share Issue/Capital Change
2021-10-29 English
Intimation
Board/Management Information
2021-10-29 English
Intimation
Regulatory Filings
2021-10-29 English
outcome of board meeting and results of Q2FY22
Interim / Quarterly Report H1 2022
2021-10-29 English
Intimation of loss of share certificates
Regulatory Filings
2021-10-27 English
Intimation
Major Shareholding Notification
2021-10-22 English
FORM 6-K
Regulatory Filings
2021-10-19 English
Dr. Reddy''s Laboratories announces approval for Lenalidomide Capsules from the U.S. Food and Drug Administration (USFDA)
Regulatory Filings
2021-10-19 English
FORM 6-K
Regulatory Filings
2021-10-18 English
Press Release
Regulatory Filings
2021-10-15 English
FORM 6-K
Regulatory Filings
2021-10-15 English
Intimation
Capital/Financing Update
2021-10-14 English
Intimation of loss of share certificate
Major Shareholding Notification
2021-10-13 English
FORM 6-K
Regulatory Filings
2021-10-07 English
Dr. Reddy''s to release Q2 FY 22 results on October 29th, 2021 Earnings call slated for October 29th @ 5:30 PM IST / 8:00 AM EDT
Regulatory Filings
2021-10-07 English
Duplicate shares notification
Regulatory Filings
2021-10-06 English
FORM 6-K
Regulatory Filings
2021-09-27 English
The trading window for dealing in securities of the Company will be closed from Friday, October 1, 2021 and ending on Sunday, October 31, 2021 (both days inclusive).
Board/Management Information
2021-09-24 English
DR.REDDY''s LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/10/2021 ,inter alia, to consider and approve the unaudited Financial ....
Board/Management Information
2021-09-24 English
FORM 6-K
Regulatory Filings
2021-09-22 English
ESOP allotment
Share Issue/Capital Change
2021-09-22 English
FORM 6-K
Regulatory Filings
2021-09-10 English
intimation
Capital/Financing Update
2021-09-09 English
FORM 6-K
Regulatory Filings
2021-09-07 English
FORM 6-K
Regulatory Filings
2021-09-07 English
Dr. Reddy's launches Minoxidil for women following first-ever approval in India for the treatment of female pattern hair loss.
Regulatory Filings
2021-09-07 English
Dr. Reddy's Laboratories enters into definitive agreement with Citius Pharmaceuticals, Inc. to sell its rights to anti-cancer agent E7777 (denileukin diftitox).
Capital/Financing Update
2021-09-04 English
FORM 6-K
Regulatory Filings
2021-09-03 English
Allotment of Equity Shares on exercise of ESOP
Share Issue/Capital Change
2021-09-02 English
FORM 6-K
Regulatory Filings
2021-09-02 English
Dr. Reddy''s Laboratories Canada announces the launch of Reddy-Lenalidomide, one of the first generic medications of its kind for the Canadian Market.
Regulatory Filings
2021-09-02 English
FORM 6-K
Regulatory Filings
2021-08-31 English
Dr. Reddy''s Laboratories announces the launch of Chlordiazepoxide Hydrochloride and Clidinium Bromide Capsules, USP in the U.S. Market
Regulatory Filings
2021-08-31 English
Dr. Reddy''s Laboratories announces the launch of Chlordiazepoxide Hydrochloride and Clidinium Bromide Capsules, USP in the U.S. Market
Regulatory Filings
2021-08-31 English
Details of Loss of Share Certificate
Regulatory Filings
2021-08-25 English
6-K Filing
Regulatory Filings
2021-08-10 English
Allotment of Equity Shares on exercise of ESOP
Share Issue/Capital Change
2021-08-09 English
Issue of Duplicate Share Certificates
Share Issue/Capital Change
2021-08-06 English
FORM 6-K
Regulatory Filings
2021-08-04 English
Dr. Reddy's Laboratories announces entry into definitive agreement with BioDelivery Sciences International, Inc., to sell its U.S. and Canada territory rights for ELYXYB (celecoxib oral ....
Capital/Financing Update
2021-08-04 English
FORM 6-K
Regulatory Filings
2021-08-03 English
FORM 6-K
Regulatory Filings
2021-08-03 English
Dr. Reddy's announces the re-launch of over-the-counter Naproxen Sodium Tablets USP, 220 mg, store-brand equivalent of Aleve® in the U.S. Market.
Capital/Financing Update
2021-08-03 English
FORM 6-K
Regulatory Filings
2021-08-02 English
Transcript of the Earnings call conducted on July 27, 2021
Call Transcript
2021-08-02 English
Dr. Reddy''s Laboratories to participate at the Fireside Chat with Investec Capital Services
Regulatory Filings
2021-08-02 English
FORM 6-K
Regulatory Filings
2021-07-29 English
Outcome of 37th Annual General Meeting & Voting results
Declaration of Voting Results & Voting Rights Announcements
2021-07-28 English
Outcome of 37th Annual General Meeting & Voting results.
Declaration of Voting Results & Voting Rights Announcements
2021-07-28 English
Financial Results
Regulatory Filings
2021-07-28 English
Earnings Call audio recording
Regulatory Filings
2021-07-28 English
Form 6-K for Q1-FY22 filed with US SEC
Interim / Quarterly Report Q1 2022
2021-07-27 English
FORM 6-K
Regulatory Filings
2021-07-27 English
FORM 6-K
Interim / Quarterly Report
2021-07-27 English
Dr. Reddy's and ICICI Lombard collaborate for pilot launch of first-of-its-kind integrated and cashless digital health solution in India.
Regulatory Filings
2021-07-27 English
Unaudited Financial Results for the quarter ended June 30, 2021
Interim / Quarterly Report Q1 2022
2021-07-27 English
6-K Filing
Regulatory Filings
2021-07-27 English
Intimation of loss of share certificates.
Regulatory Filings
2021-07-21 English
FORM 6-K
Regulatory Filings
2021-07-07 English
Dr. Reddy''s to release Q1 FY 22 results on July 27th, 2021 Earnings call slated for July 27th @ 5:30 PM IST / 8:00 AM EDT
Earnings Release Q1 2022
2021-07-07 English
Loss of Share Certificates.
Regulatory Filings
2021-07-07 English
FORM 6-K
Regulatory Filings
2021-07-06 English
Newspaper advertisement regarding notice of 37th annual general meeting of the company and e-voting information.
AGM Information
2021-07-03 English
FORM 6-K
AGM Information
2021-07-02 English
Pursuant to Regulation 34 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015, please find enclosed Notice convening the 37th AGM of the Company and Annual ....
Annual Report FY 2021
2021-07-02 English
Reply to clarification sought
Regulatory Filings
2021-07-02 English
FORM 6-K
Report Publication Announcement
2021-07-01 English
Dr. Reddy''s Laboratories announces filing of Annual Report on Form 20-F
Report Publication Announcement
2021-06-30 English
FORM 20-F
Annual Report FY 2021
2021-06-30 English
FORM 6-K
Regulatory Filings
2021-06-29 English
Pharma Majors Collaborate for Clinical Trial of Investigational Oral Anti-Viral Drug Molnupiravir for COVID-19
Regulatory Filings
2021-06-29 English
FORM 6-K
Regulatory Filings
2021-06-28 English
Dr. Reddy's Laboratories Announces Commercial Launch of 2DG
Regulatory Filings
2021-06-28 English
6-K Filing
Regulatory Filings
2021-06-28 English
The trading window for dealing in securities of the Company will be closed from Thursday, July 1, 2021 to Thursday, July 29, 2021 (both days inclusive).
Board/Management Information
2021-06-25 English
DR.REDDY''s LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/07/2021 ,inter alia, to consider and approve the unaudited Financial ....
Board/Management Information
2021-06-25 English
Allotment of Equity Shares on exercise of ESOP
Share Issue/Capital Change
2021-06-24 English
6-K Filing
Regulatory Filings
2021-06-24 English
Dr. Reddy''s Laboratories announces the launch of Icosapent Ethyl Capsules, 1 gram in the U.S. Market
Regulatory Filings
2021-06-22 English
6-K Filing
Regulatory Filings
2021-06-22 English
FORM 6-K
Regulatory Filings
2021-06-15 English
Intimation
Regulatory Filings
2021-06-15 English
Newspaper publication on book closure date and date of AGM
AGM Information
2021-06-15 English
Loss of Share Certificates
Regulatory Filings
2021-06-14 English
Disclosure of related party transactions for the half year ended March 31, 2021
Regulatory Filings
2021-06-10 English
Issue of Duplicate Share Certificates
Regulatory Filings
2021-06-09 English
FORM 6-K
Regulatory Filings
2021-06-04 English
Allotment of Equity Shares on exercise of ESOPs.
Share Issue/Capital Change
2021-06-03 English
FORM 6-K
Regulatory Filings
2021-05-24 English
Newspaper advertisement for registration of e-mail address and updation of bank details of shareholders.
Regulatory Filings
2021-05-23 English
6-K Filing
Regulatory Filings
2021-05-21 English
Intimation of date of Annual General Meeting
AGM Information
2021-05-19 English
Intimation of Book Closure.
AGM Information
2021-05-19 English
6-K Filing
Regulatory Filings
2021-05-19 English
Transcript of the Earnings call conducted on May 14, 2021
Call Transcript
2021-05-18 English
Annual Secretarial Compliance Report
Regulatory Filings
2021-05-18 English
6-K Filing
Regulatory Filings
2021-05-17 English
Newspaper advertisement for transfer of equity shares to IEPF.
Regulatory Filings
2021-05-15 English
Financial Results
Regulatory Filings
2021-05-15 English
Earnings Call audio recording
Regulatory Filings
2021-05-15 English
FORM 6-K
Regulatory Filings
2021-05-14 English
FORM 6-K
Regulatory Filings
2021-05-14 English
Grant of Stock Options
Remuneration Information
2021-05-14 English
Board approves Dividend
Annual Report FY 2021
2021-05-14 English
Dr Reddys Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 14, 2021, inter alia, have recommended a final dividend of Rs. 25/- (500%) ....
Interim / Quarterly Report FY 2021
2021-05-14 English
Outcome of Board Meeting - Audited Financial Results for the quarter and year ended March 31, 2021.
Interim / Quarterly Report FY 2021
2021-05-14 English
Dr. Reddy's Laboratories Announces Launch of the Sputnik V vaccine in the Indian Market
Regulatory Filings
2021-05-14 English
FORM 6-K
Regulatory Filings
2021-05-12 English
Dr. Reddy''s Laboratories announces the launch of Ertapenem for Injection in the U.S. Market.
Regulatory Filings
2021-05-11 English
Mr. Bharat Narotam Doshi, Independent Director of the Company has ceased to be a Director of the Company with effect from May 10, 2021 on completion of his term as independent director.
Board/Management Information
2021-05-11 English
Dr. Reddy''s Laboratories enters into a Voluntary Licensing Agreement with Lilly to Expand Access to COVID-19 Treatment in India
Regulatory Filings
2021-05-11 English
FORM 6-K
Regulatory Filings
2021-05-10 English
Intimation for withdrawal of Credit Rating
Regulatory Filings
2021-05-08 English
FORM 6-K
M&A Activity
2021-05-03 English
Update on acquisition.
Major Shareholding Notification
2021-04-30 English
FORM 6-K
Regulatory Filings
2021-04-29 English
Dr. Reddy''s Laboratories announces the launch of Albendazole Tablets, USP in the U.S. Market.
Capital/Financing Update
2021-04-29 English
Dr. Reddy''s Laboratories announces the launch of Albendazole Tablets, USP in the U.S. Market.
Capital/Financing Update
2021-04-29 English
FORM 6-K
Regulatory Filings
2021-04-23 English
Dr. Reddy''s to release Q4 and full year FY 21 results on May 14th, 2021 Earnings call slated for May 14th @ 5:30 PM IST / 8:00 AM EDT
Regulatory Filings
2021-04-23 English
Certificate under Regulation 40(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the half year ended March 31, 2021.
Regulatory Filings
2021-04-19 English
Compliance certificate pursuant to Regulation 7(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings
2021-04-15 English
FORM 6-K
Regulatory Filings
2021-04-13 English
Dr. Reddy''s Laboratories Gets Emergency Use Authorisation for Sputnik V in India.
Regulatory Filings
2021-04-13 English
Issue of duplicate share certificate
Regulatory Filings
2021-04-09 English
FORM 6-K
Regulatory Filings
2021-04-07 English
Dr. Reddy''s Laboratories announces the launch of a generic version of Sapropterin Dihydrochloride Powder for Oral Solution, 100 mg in the U.S. Market.
Regulatory Filings
2021-04-07 English
FORM 6-K
Regulatory Filings
2021-04-01 English
We would like to inform you that DigiHealth Technologies LLP, the wholly owned entity of our Indian investee entity i.e. ABCD Technologies LLP (to be renamed as IndoHealth Services LLP), ....
Capital/Financing Update
2021-04-01 English
Board Meeting Notice - Advertisement
AGM Information
2021-04-01 English
FORM 6-K
Regulatory Filings
2021-04-01 English
We would like to inform you that our investee entity i.e. ABCD Technologies LLP (to be renamed as IndoHealth Services LLP) has, through its wholly-owned entity DigiHealth Technologies LLP, ....
Regulatory Filings
2021-03-31 English
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Company has entered into a partnership agreement ....
Capital/Financing Update
2021-03-31 English
The Exchange has received the disclosure under Regulation 10(7) in respect of acquisition under Regulation 10(1)(a)(ii)of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, ....
Major Shareholding Notification
2021-03-30 English
FORM 6-K
Regulatory Filings
2021-03-29 English
Dr Reddys Laboratories Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 14, 2021, inter alia, to consider and approve the Audited Financial ....
Board/Management Information
2021-03-29 English
The trading window for dealing in securities of the Company will be closed from Thursday, April 1, 2021 to Sunday, May 16, 2021 (both days inclusive).
Board/Management Information
2021-03-29 English
DR.REDDY''s LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/05/2021 ,inter alia, to consider and approve Dr. Reddy''s Laboratories ....
Board/Management Information
2021-03-29 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Gunupati Venkateswara Prasad - HUF
Major Shareholding Notification
2021-03-26 English
The Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Gunupati Venkateswara Prasad - HUF
Major Shareholding Notification
2021-03-26 English
6-K Filing
Regulatory Filings
2021-03-22 English
Allotment of Equity Shares on exercise of ESOP.
Share Issue/Capital Change
2021-03-19 English
The Exchange has received the disclosure under Regulation 10(5) in respect of acquisition under Regulation 10(1)(a) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, ....
Regulatory Filings
2021-03-19 English
FORM 6-K
Regulatory Filings
2021-03-10 English
Intimation
Regulatory Filings
2021-03-10 English
Issue of duplicate share certificates.
Regulatory Filings
2021-03-09 English
FORM 6-K
Regulatory Filings
2021-03-01 English
Allotment of Equity Shares on exercise of ESOP
Share Issue/Capital Change
2021-03-01 English
FORM 6-K
Regulatory Filings
2021-02-22 English
Dr. Reddy''s Laboratories announces the launch of Lansoprazole DR Orally Disintegrating Tablets in the U.S. Market.
Regulatory Filings
2021-02-22 English
FORM 6-K
Regulatory Filings
2021-02-19 English
Dr. Reddy''s initiates process for Emergency Use Authorization of Sputnik V
Regulatory Filings
2021-02-19 English
FORM 6-K
Regulatory Filings
2021-02-18 English
Dr. Reddy''s Laboratories announces the launch of Fluphenazine Hydrochloride Tablets, USP in the U.S. Market
Regulatory Filings
2021-02-18 English
FORM 6-K
Regulatory Filings
2021-02-17 English
Dr. Reddy''s Laboratories announces the launch of Capecitabine Tablets, USP in the U.S. Market.
Regulatory Filings
2021-02-17 English
Loss of Share Certificate
Regulatory Filings
2021-02-16 English
Loss of Share Certificate
Regulatory Filings
2021-02-10 English
Issue of Duplicate Share Certificates
Regulatory Filings
2021-02-10 English
Form 6K for Q3-FY21 filed with US SEC
Interim / Quarterly Report 9M 2021
2021-02-04 English
Form 6K for Q3-FY21 filed with US SEC
Interim / Quarterly Report 9M 2021
2021-02-04 English
6-K Filing
Interim / Quarterly Report
2021-02-03 English
FORM 6-K
Regulatory Filings
2021-02-02 English
SCHEDULE 13G AMENDMENT NO. 1
Major Shareholding Notification
2021-02-02 English
Dr. Reddy''s Laboratories announces the launch of Vigabatrin Tablets, USP in the U.S. Market.
Regulatory Filings
2021-02-02 English
6-K Filing
Regulatory Filings
2021-02-01 English
Newspaper Publication- Financial Results
Regulatory Filings
2021-01-31 English
FORM 6-K
Regulatory Filings
2021-01-29 English
Unaudited Financial Results for the quarter and nine months ended December 31, 2020.
Interim / Quarterly Report 9M 2021
2021-01-29 English
FORM 6-K
Regulatory Filings
2021-01-27 English
Dr. Reddy's and GRA announces Avigan Pivotal Studies Update
Regulatory Filings
2021-01-27 English
FORM 6-K
Regulatory Filings
2021-01-15 English
Dr. Reddy's receives approval to conduct Phase 3 clinical trial for Sputnik V vaccine in India.
Regulatory Filings
2021-01-15 English
Press Release
Regulatory Filings
2021-01-11 English
Press Release
Investor Presentation
2021-01-11 English
FORM 6-K
Regulatory Filings
2021-01-11 English
Press Release
Regulatory Filings
2021-01-11 English
6-K Filing
Regulatory Filings
2021-01-11 English
Press Release
Regulatory Filings
2021-01-08 English
6-K Filing
Regulatory Filings
2021-01-08 English
Issue of Duplicate Share Certificates
Regulatory Filings
2021-01-04 English